NIH-funded research U01 cooperative agreement

AI-built genetic map to understand Alzheimer's disease

Official title: AIM-AI: an Actionable, Integrated and Multiscale genetic map of Alzheimer's disease via deep learning

Funded at University of Texas Hlth Sci Ctr Houston · NIH-11180316 · Data updated 2026-11-12

Using artificial intelligence to combine genetic, molecular, and brain imaging data to find genetic clues that could help people with or at risk for Alzheimer's disease.

More s Disease research and trials

Quick facts

Grant typeU01 cooperative agreement
Study typeNIH-funded research
Funding institutionUniversity of Texas Hlth Sci Ctr Houston
NIH-funded
Lab location1 site (Houston, United States)
Project startSeptember 15, 2023
Project endAugust 31, 2028
Funding year2025
Award (this year)$1,259,982
NIH project number5U01AG079847-03
Project IDNIH-11180316 on NIH RePORTER

Who could benefit from this research

Could help

People with Alzheimer's disease, mild cognitive impairment, or individuals at genetic risk who can provide genetic samples, brain imaging, or other research data are ideal candidates.

Less likely to help

Those seeking an immediate new therapy or people whose cognitive problems are due to non-Alzheimer causes may not receive direct clinical benefit from this work.

What this research studies

This project will use AI to analyze large collections of genetic information, brain scans, and other molecular data from people with Alzheimer's or at risk. Researchers will link gene changes to specific brain cell types and regions using single-cell and other 'omics' data alongside neuroimaging. The team aims to turn complex genetic signals into a clear, multiscale map that points to biological processes and possible drug targets. If you contribute data or samples, your information could help guide future tests and therapies.

Why it matters

Potential benefit: Could reveal clearer genetic targets for new treatments or better tests to predict or understand Alzheimer's disease.

How similar studies have gone: Prior AI and genetic studies have found promising signals in Alzheimer's, but a fully integrated, multiscale AI genetic map of the kind proposed remains relatively new.

Where this research is happening

  • University of Texas Hlth Sci Ctr Houston
    Houston, United States
    Active

Researchers

  • Principal investigator: Zhao, Zhongming — University of Texas Hlth Sci Ctr Houston
  • Study coordinator: Zhao, Zhongming

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.